Loading...
Indian Pharmaceutical Exporter · #3 for Device · $5.9M export value · DGFT Verified
S M B Corporation Of India is the #3 Indian exporter of Device with $5.9M in export value and 369 verified shipments. S M B Corporation Of India holds a 24.2% market share in Device exports across 56 countries.
| MOROCCO | $206.8K | 8 | 4.9% |
| PAKISTAN | $175.7K | 7 | 4.1% |
| UNITED KINGDOM | $145.7K | 3 | 3.4% |
| ZAMBIA | $101.7K | 6 | 2.4% |
| SPAIN | $101.5K | 22 | 2.4% |
| POLAND | $95.1K | 25 | 2.2% |
S M B Corporation Of India exports Device to 56 countries. The largest destination is FRANCE accounting for 24.0% of S M B Corporation Of India's Device shipments, followed by BRAZIL (20.3%) and EGYPT (15.1%). These destinations reflect S M B Corporation Of India's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LABORATOIRE CCD | FRANCE | $732.0K | 22 |
| EXELTIS LABORATRIO FARMACEUTICO LT | BRAZIL | $364.0K | 16 |
| TECHNO PHARMA FOR INVESTMENT AND DE | EGYPT | $353.2K | 11 |
| TECHNO PHARMA FOR INVESTMENT AND | EGYPT | $239.4K | 6 |
| EXELTIS LABORAT?RIO FARMACEUTICO LT | BRAZIL | $225.7K | 7 |
| CEPEO CONTRACEPTIVOS LTD | BRAZIL | $223.5K | 6 |
| LABORATOIRE CCD. | FRANCE | $216.9K | 5 |
| CREDIT AGRICOLE DU MAROC | MOROCCO | $199.6K | 4 |
| GALENA SAGLIK SAN. VE TIC. A.S. | TURKEY | $94.8K | 4 |
| MARIE STOPES ZAMBIA | ZAMBIA | $94.7K | 5 |
S M B Corporation Of India supplies Device to 109 buyers globally. The largest buyer is LABORATOIRE CCD (FRANCE), followed by EXELTIS LABORATRIO FARMACEUTICO LT (BRAZIL) and TECHNO PHARMA FOR INVESTMENT AND DE (EGYPT). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $17.7M worth of Device through 2,752 shipments from 154 suppliers to 150 countries, serving 692 buyers globally. S M B Corporation Of India contributes $5.9M to this total, accounting for 24.2% of India's Device exports. S M B Corporation Of India ships Device to 56 countries through 109 buyers.
S M B Corporation Of India's average Device shipment value is $16.0K per consignment, based on 369 shipments totaling $5.9M. The largest destination is FRANCE (24.0% of S M B Corporation Of India's Device exports).
S M B Corporation Of India ranks #3 among 154 Indian Device exporters with a 24.2% market share. The top 3 exporters are PREGNA INTERNATIONAL LIMITED ($7.1M), S M B CORPORATION OF INDIA ($5.9M), CORPORATE CHANNELS (INDIA) PVT. LTD ($2.0M). S M B Corporation Of India processed 369 shipments to 56 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Intrauterine Contraceptive Device (IUD) | $219.7K | 6 |
| INTRAUTERINE DEVICE (IUD) - LIBRENE TCU380A (TCU 380A) (CATCH COVER PACKAGING)REGISTRATION NO :- 80117580783 | NCM NUM | $187.8K | 6 |
| CE Marked- Intrauterine Devices - TCu 38 | $174.9K | 4 |
| CE MARKED- Intrauterine Devices IUD TCu 380Ag Normal With Catch Cover | $150.0K | 3 |
| CE MARKED INTRAUTERINE DEVICES & ACCESSO | $124.5K | 3 |
| CE MARKED -INTRAUTERINE CONTRACEPTIVE DEVICES (IUDS) TCU 380ANOS | $116.5K | 3 |
| CE MARKED STERILE COPPER T 380A WITH SAFE LOAD AND PROBE - INTRAUTERINE CONTRACEPTIVE DEVICES | $100.0K | 2 |
| CE MARKED -Intrauterine Contraceptive Devices IUDs Cu 375 Standard | $100.0K | 2 |
| CE MARKED STERILE COPPER T 380A WITH CATCH COVER - INTRAUTERINE CONTRACEPTIVE DEVICES | $99.6K | 2 |
| CE Marked (Intrauterine Devices Access | $98.6K | 3 |
S M B Corporation Of India exports 262 distinct Device formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Intrauterine Contraceptive Device (IUD) with 6 shipments worth $219.7K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
What S M B Corporation Of India must comply with to export Device to its top destination countries
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | PREGNA INTERNATIONAL LIMITED | $7.1M | 363 | 67 | $19.4K |
| 3 | S M B CORPORATION OF INDIA ★ | $5.9M | 369 | 56 | $16.0K |
| 1 | CORPORATE CHANNELS (INDIA) PVT. LTD | $2.0M | 41 | 20 | $50.0K |
| 4 | NEWTEC IMPEX | $920.2K | 35 | 2 | $26.3K |
S M B Corporation Of India ranks #3 among 154 Indian Device exporters. Average shipment value of $16.0K compared to the market average of $115.1K. The closest competitors by value are PREGNA INTERNATIONAL LIMITED and CORPORATE CHANNELS (INDIA) PVT. LTD.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 459 | 16.7% |
| DELHI AIR CARGO ACC (INDEL4) | 338 | 12.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 284 | 10.3% |
| Bombay Air | 250 | 9.1% |
| DELHI AIR | 228 | 8.3% |
| CHENNAI AIR | 144 | 5.2% |
| JNPT/ NHAVA SHEVA SEA | 93 | 3.4% |
| NHAVA SHEVA SEA (INNSA1) | 92 | 3.3% |
Latest developments and market context
Detailed market intelligence for Device — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 150+ countries, 692+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for S M B Corporation Of India's Device exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
S M B Corporation Of India
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for S M B Corporation Of India.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Device. For current shipment-level data, contact TransData Nexus.